VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 122 filers reported holding VERVE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,179,455 | -11.5% | 2,954,710 | +25.2% | 4.34% | +12.1% |
| Q2 2023 | $44,260,706 | +44.7% | 2,360,571 | +11.3% | 3.87% | +53.6% |
| Q1 2023 | $30,578,634 | -31.0% | 2,120,571 | -7.4% | 2.52% | -26.6% |
| Q4 2022 | $44,322,549 | -59.4% | 2,290,571 | -27.9% | 3.43% | -52.1% |
| Q3 2022 | $109,170,000 | +127.7% | 3,178,167 | +1.3% | 7.17% | +76.9% |
| Q2 2022 | $47,951,000 | -33.0% | 3,138,167 | 0.0% | 4.05% | +26.3% |
| Q1 2022 | $71,613,000 | -38.1% | 3,138,167 | 0.0% | 3.21% | -1.5% |
| Q4 2021 | $115,704,000 | -19.0% | 3,138,167 | +3.3% | 3.26% | -8.2% |
| Q3 2021 | $142,794,000 | -22.0% | 3,038,167 | 0.0% | 3.55% | -23.5% |
| Q2 2021 | $183,050,000 | – | 3,038,167 | – | 4.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $515,778,000 | 12.24% |
| Casdin Capital, LLC | 3,038,167 | $142,794,000 | 3.55% |
| Redmile Group, LLC | 1,869,030 | $87,844,000 | 1.53% |
| Logos Global Management LP | 443,265 | $20,833,000 | 1.50% |
| Novo Holdings A/S | 600,000 | $28,200,000 | 1.46% |
| Cormorant Asset Management, LP | 709,224 | $32,667,000 | 1.33% |
| Rock Springs Capital Management LP | 962,826 | $45,253,000 | 0.95% |
| HighVista Strategies LLC | 18,782 | $883,000 | 0.58% |
| RA Capital Management | 880,284 | $41,373,000 | 0.57% |
| Nicholas Investment Partners, LP | 132,300 | $6,218,000 | 0.45% |